Plain-English translation of NCT06523179 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why some people with fatty liver disease develop liver cancer while others don't. This study will look at genetic factors—inherited traits that may increase cancer risk—by collecting blood samples and analyzing your DNA. The goal is to create a better way to predict who is at highest risk, so doctors can watch those patients more closely and potentially prevent cancer from developing.
Fatty liver disease is becoming very common, especially in people with obesity or diabetes, but we don't fully understand which genetic factors make some people more likely to develop liver cancer. By identifying these genetic risk factors, doctors hope to find people at highest risk earlier and develop better ways to prevent the disease.
You likely qualify if…
You likely don't qualify if…
This is a research study focused on genetics, not a treatment trial. You would be asked to provide a blood sample so researchers can analyze your DNA and look for genetic variants associated with liver cancer risk. The study has two phases: first, researchers will examine known genetic risk factors, and later they may use advanced sequencing techniques to discover new genetic risk factors. You would likely have visits to provide samples and answer questions about your health history, family background, and any symptoms you're experiencing.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy